Abeona Therapeutics (ABEO) Interest Income - Net (2021 - 2026)
Abeona Therapeutics (ABEO) recorded quarterly Interest Income - Net of $524000.0 in Q1 2026, down 20.97% quarter-over-quarter from $663000.0 in Q4 2025, and up 67.95% on a YoY basis from $312000.0 in Q1 2025.
Abeona Therapeutics (ABEO) Interest Income - Net (2021 - 2026) Analysis & Trends
Abeona Therapeutics' Interest Income - Net history runs 6 years deep, the most recent figure standing at $524000.0 for Q1 2026.
- In Q1 2026, Interest Income - Net rose 67.95% year-over-year to $524000.0; the TTM figure through Mar 2026 stood at $2.0 million (up 341.83% YoY), while the FY2025 annual figure was $1.8 million, up 4678.95% from the prior year.
- Interest Income - Net was $524000.0 for Q1 2026 at Abeona Therapeutics, down from $663000.0 in the prior quarter.
- In the past five years, Interest Income - Net ranged from a high of $771000.0 in Q3 2025 to a low of -$194000.0 in Q1 2022.
- Historically, Interest Income - Net has averaged $222294.1 across 5 years, with a median of $150000.0 in 2022.
- The sharpest annual moves came in 2024 and 2025: Interest Income - Net tumbled 141.44% in 2024, then surged 1223.73% in 2025.
- A 5-year view of Interest Income - Net shows it stood at $150000.0 in 2022, then surged by 322.67% to $634000.0 in 2023, then tumbled by 109.31% to -$59000.0 in 2024, then soared by 1223.73% to $663000.0 in 2025, then slipped by 20.97% to $524000.0 in 2026.
- The last three Interest Income - Net figures came in at $524000.0 (Q1 2026), $663000.0 (Q4 2025), and $771000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Net (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Abeona Therapeutics | 309.15 Mn | 140.88 Mn | 6.02 Mn | 524,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 524,000.00 |
| Dec 31, 2025 | 663,000.00 |
| Sep 30, 2025 | 771,000.00 |
| Jun 30, 2025 | 70,000.00 |
| Mar 31, 2025 | 312,000.00 |
| Dec 31, 2024 | -59,000.00 |
| Sep 30, 2024 | 87,000.00 |
| Jun 30, 2024 | 119,000.00 |
| Mar 31, 2024 | -109,000.00 |
| Dec 31, 2023 | 634,000.00 |
| Sep 30, 2023 | 488,000.00 |
| Jun 30, 2023 | 314,000.00 |
| Mar 31, 2023 | 263,000.00 |
| Dec 31, 2022 | 150,000.00 |
| Sep 30, 2022 | -85,000.00 |
| Jun 30, 2022 | -169,000.00 |
| Mar 31, 2022 | -194,000.00 |
| Dec 31, 2021 | -48,000.00 |
| Sep 30, 2021 | -676,000.00 |